Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 37
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Gastroenterol Res Pract ; 2013: 462891, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23476637

RESUMO

Introduction. This study aimed to evaluate symptoms and signs, inflammation markers, electrolytes, and ECG signs of increased vagal tone as markers of colon perforation in sigmoid diverticulitis or appendicitis. Methods. The records of all patients older than fifty years (only these had routine ECG done) admitted to our emergency station between January 2008 and December 2010 with sigmoid diverticulitis (n = 198, diagnosed by computer tomography) or appendicitis (n = 84, diagnosed intraoperatively) were retrospectively evaluated. Pain score, heart rate, blood pressure, and body temperature were assessed at presentation. Before starting infusion therapy, blood was taken to do a blood count and to analyze CRP, the electrolytes, and creatinine levels. Then an ECG was done. Results. The perforation rate was 37% (n = 103). Body temperature, heart rate, sodium, CRP, and leukocytes correlated significantly with infectious colon perforation. However, only body temperature, CRP, and sodium correlated significantly with infectious colon perforation if compared by logistic regression analysis. The prevalence of hyponatremia (sodium level <136 mmol/L) was 29% in the group with infectious colon perforation and 16% in the group without (P = 0.013). Conclusion. Hyponatremia is a specific marker of infectious colon perforation in patients older than fifty years.

3.
Praxis (Bern 1994) ; 88(39): 1573-80, 1999 Sep 23.
Artigo em Alemão | MEDLINE | ID: mdl-10540569

RESUMO

A pericardial effusion is a relatively common disease confronting the clinician. The most frequent causes are neoplasias (lung, breast and ovarial carcinoma, leukemia and lymphoma) uremia or idiopathic. Infections (frequently virus and seldom bacteria), myocardial infarction and rheumatic disease are also common. We present the clinical picture, the differential diagnosis and the various investigations of the pericardial effusion.


Assuntos
Derrame Pericárdico/diagnóstico , Derrame Pericárdico/terapia , Diagnóstico Diferencial , Feminino , Humanos , Pessoa de Meia-Idade , Admissão do Paciente , Derrame Pericárdico/diagnóstico por imagem , Pericardite/diagnóstico , Pericardite/diagnóstico por imagem , Radiografia , Ultrassonografia
4.
Praxis (Bern 1994) ; 88(21): 951-2, 1999 May 20.
Artigo em Alemão | MEDLINE | ID: mdl-10412282

RESUMO

The effect of trophotropic (relaxing) music on heart rate and heart rate variability has been investigated in 23 healthy young individuals by means of 24-hour Holter-ECG. Relaxing music (Bach, Vivaldi, Mozart) resulted in significant reduction of heart rate and also significant reduction of heart rate variability. The significance of these results for the use of music in coronary heart disease is discussed.


Assuntos
Eletrocardiografia Ambulatorial , Frequência Cardíaca , Musicoterapia , Adolescente , Doença das Coronárias/terapia , Feminino , Humanos , Masculino
7.
J Cardiovasc Pharmacol ; 32(4): 637-41, 1998 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9781933

RESUMO

The acute effects of various vasopressor agents on the diameter of the common carotid artery were studied in halothane-anesthetized normotensive rats. The animals were infused intravenously for 60 min with equipressor doses of angiotensin II (10 ng/min), the alpha1-stimulant methoxamine (5 microg/min), lysine vasopressin (5 mU/min), or vehicle. The arterial diameter was measured by using a high-resolution ultrasonic echo-tracking device. The three vasoconstrictors increased the carotid artery diameter, but this effect was significantly more pronounced with lysine vasopressin. Even a nonpressor dose of lysine vasopressin (1 mU/min) caused a significant increase in the arterial diameter. The lysine vasopressin-induced vasodilatation could be prevented by the administration of d(CH2)5Tyr(Me)AVP (10 microg, i.v.), a selective V1-vasopressinergic receptor antagonist. These data therefore suggest that a short-term increase in blood pressure induces in rats a distention of the carotid artery. The increase in arterial diameter seems to involve an active mechanism with lysine vasopressin caused by the stimulation of V1-vasopressinergic receptors.


Assuntos
Arginina Vasopressina/análogos & derivados , Antagonistas de Hormônios/farmacologia , Receptores de Vasopressinas/efeitos dos fármacos , Vasoconstritores/farmacologia , Vasodilatação/efeitos dos fármacos , Angiotensina II/antagonistas & inibidores , Angiotensina II/farmacologia , Animais , Antagonistas dos Receptores de Hormônios Antidiuréticos , Arginina Vasopressina/farmacologia , Pressão Sanguínea/efeitos dos fármacos , Artérias Carótidas/efeitos dos fármacos , Frequência Cardíaca/efeitos dos fármacos , Infusões Intravenosas , Lipressina/antagonistas & inibidores , Lipressina/farmacologia , Masculino , Metoxamina/farmacologia , Ratos , Ratos Wistar , Vasoconstrição/efeitos dos fármacos , Vasoconstritores/antagonistas & inibidores
9.
Vasa ; 26(1): 49-51, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9068266

RESUMO

Recurrent pulmonary emboli may be due to numerous causes and deep vein thrombosis are not an unusual source of pulmonary emboli following surgery. In this case report, the diagnostic approach and implications of a right ventricular myxoma as a rare source in a young patient is described. A 27-year old healthy woman presented scintigraphically proven recurrent pulmonary emboli after primary ligament reconstruction. Following a long period of diagnostic work-up for thromboembolism after surgery, a transthoracic and transoesophageal echocardiography was performed to document a right ventricular myxoma. Both transthoracic and transoesophageal echocardiography are powerful diagnostic means in a cardiac work-up and were used in this patient for the documentation of a right ventricular myxoma mimicking deep vein thromboembolism after surgery. As consequence of this case report we recommend to investigate patients with recurrent pulmonary embolism and no detectable venous thrombosis by echocardiography and a need for cardiac catheterization is restricted to patients with possible coexisting coronary artery disease. Furthermore, this case report demonstrates a myxoma in the right ventricle occurring only in 3-4% of all myxomas.


Assuntos
Ligamentos Colaterais/lesões , Ecocardiografia Transesofagiana , Neoplasias Cardíacas/diagnóstico por imagem , Mixoma/diagnóstico por imagem , Complicações Pós-Operatórias/diagnóstico por imagem , Embolia Pulmonar/diagnóstico por imagem , Adulto , Ligamentos Colaterais/cirurgia , Diagnóstico Diferencial , Ecocardiografia Doppler , Feminino , Seguimentos , Neoplasias Cardíacas/patologia , Neoplasias Cardíacas/cirurgia , Humanos , Mixoma/patologia , Mixoma/cirurgia , Complicações Pós-Operatórias/patologia , Complicações Pós-Operatórias/cirurgia , Embolia Pulmonar/patologia , Embolia Pulmonar/cirurgia , Recidiva
16.
Praxis (Bern 1994) ; 85(7): 188-96, 1996 Feb 13.
Artigo em Francês | MEDLINE | ID: mdl-8701183

RESUMO

Sudden cardiac death is defined as natural death due to cardiac causes, heralded by abrupt loss of consciousness within one hour after the onset of symptoms. The mechanisms are the following: 1. ventricular fibrillation, 2. ventricular tachycardia and flutter with subsequent ventricular fibrillation, 3. torsade de pointe, 4. bradyarrhythmias and asystolic arrest. White the main risk factor is the presence of coronary artery disease, any organic or functional disease of the heart can predispose for sudden cardiac death. To evaluate the risk of sudden cardiac death noninvasive (Holter, echocardiography, exercise test and signal averaged (ECG) and often invasive (electrophysiological study) tests are necessary. The therapy is based on drugs (mainly beta blockers and amiodarone), coronary revascularization, catheter ablation techniques and the implantation of a cardioverter defibrillator; the latter appears to be the most promising approach.


Assuntos
Arritmias Cardíacas/fisiopatologia , Morte Súbita Cardíaca , Adolescente , Adulto , Idoso , Antiarrítmicos/uso terapêutico , Arritmias Cardíacas/terapia , Ablação por Cateter , Doença das Coronárias/fisiopatologia , Desfibriladores Implantáveis , Feminino , Testes de Função Cardíaca , Doenças das Valvas Cardíacas/fisiopatologia , Humanos , Hipertrofia Ventricular Esquerda/fisiopatologia , Masculino , Pessoa de Meia-Idade , Revascularização Miocárdica , Fatores de Risco , Disfunção Ventricular/fisiopatologia , Desequilíbrio Hidroeletrolítico/fisiopatologia
17.
Am J Hypertens ; 9(2): 137-43, 1996 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8924263

RESUMO

The relationship between the Ca2+ transport of platelet endoplasmic reticulum and hypertension was analyzed in 17 untreated patients exhibiting various degrees of hypertension. Each patient underwent a 24-h recording of ambulatory blood pressure. Platelets from patients were permeabilized with saponin and the rate of ATP-driven thapsigargin-sensitive Ca2+ uptake determined using the fluorescent Ca2+ indicator fluo-3. No relationship between blood pressure (systolic, diastolic, day, night) and the rate of Ca2+ uptake into the sacroplasmic reticulum of platelets was found. A weak but insignificant correlation between Ca2+ uptake and the heart rate was noted. Therefore, the increase in cytosolic Ca2+ of platelets in hypertension may not be due to changes of the activity of Ca2+ uptake into the sacroplasmic reticulum.


Assuntos
Plaquetas/metabolismo , Cálcio/sangue , Hipertensão/sangue , Membranas Intracelulares/metabolismo , Adulto , Compostos de Anilina , Pressão Sanguínea , Feminino , Corantes Fluorescentes , Frequência Cardíaca , Humanos , Hipertensão/fisiopatologia , Masculino , Pessoa de Meia-Idade , Valores de Referência , Retículo Sarcoplasmático/metabolismo , Xantenos
18.
Nephron ; 73(3): 467-72, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8832609

RESUMO

Neuropeptide Y (NPY) is a vasoconstrictor peptide possibly involved in the regulation of renal sodium handling and renin release. This investigation was undertaken to assess in conscious normotensive rats the acute effects of a non-pressor dose of NPY on renal plasma flow, glomerular filtration rate, sodium excretion and plasma renin activity. Experiments were also performed during concomitant beta-adrenoceptor stimulation with isoproterenol. NPY per se had no effect on the studied parameters. Renal plasma flow was increased by isoproterenol and was significantly higher when the beta-adrenoceptor stimulant was infused alone (13.4 +/- 2.1 ml/min, p < 0.05, mean +/- SEM) that when administered together with NPY (7.2 +/- 2.0 ml/min). This was also true for glomerular filtration rate (3.3 +/- 0.3 vs. 1.8 +/- 0.3 ml/min, p < 0.01) and plasma renin activity (6.3 +/- 1.7 vs. 2.1 +/- 0.4 ng Ang I/ml/h, p < 0.05). Our data however do not allow to deduce whether the inhibitory effect of NPY on isoproterenol-induced renin release is mediated by changes in intrarenal hemodynamics or a direct effect on juxtaglomerular cells.


Assuntos
Neuropeptídeo Y/farmacologia , Circulação Renal/efeitos dos fármacos , Renina/sangue , Sódio/urina , Agonistas Adrenérgicos beta/farmacologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Taxa de Filtração Glomerular/efeitos dos fármacos , Frequência Cardíaca/efeitos dos fármacos , Infusões Intravenosas , Isoproterenol/farmacologia , Masculino , Neuropeptídeo Y/administração & dosagem , Ratos , Ratos Wistar , Fluxo Plasmático Renal/efeitos dos fármacos , Sistema Renina-Angiotensina/efeitos dos fármacos
19.
Regul Pept ; 58(3): 163-6, 1995 Aug 22.
Artigo em Inglês | MEDLINE | ID: mdl-8577929

RESUMO

This study was undertaken to assess in conscious normotensive rats the effects of beta-adrenoceptor stimulation on plasma neuropeptide Y (NPY) levels. Wistar rats were subjected to adrenal demedullation on the right side and were either adrenalectomized or sham-operated on the left side. Eleven days later, the conscious rats were infused i.v. for 30 min with either isoproterenol (10 ng/min) or its vehicle. Plasma NPY levels were significantly lower (23.8 +/- 2.6 pM, means +/- S.E.M., n = 12, P < 0.01) in vehicle-treated medullectomized rats than in corresponding sham-operated controls (36.7 +/- 4.1 pM, n = 12). The medullectomized rats infused with isoproterenol showed plasma NPY levels (36.7 +/- 3.3 pM, n = 11) comparable to those of sham-operated rats having received the vehicle. These data therefore demonstrate that plasma NPY levels are lower in rats without adrenal medulla and that in these animals isoproterenol increases NPY release, most likely by activating pre-synaptic beta-adrenoceptors.


Assuntos
Medula Suprarrenal/fisiologia , Adrenalectomia , Agonistas Adrenérgicos beta/farmacologia , Isoproterenol/farmacologia , Neuropeptídeo Y/metabolismo , Sistema Nervoso Simpático/fisiologia , Agonistas Adrenérgicos beta/administração & dosagem , Animais , Pressão Sanguínea/efeitos dos fármacos , Epinefrina/sangue , Frequência Cardíaca/efeitos dos fármacos , Infusões Intravenosas , Isoproterenol/administração & dosagem , Masculino , Neuropeptídeo Y/sangue , Norepinefrina/sangue , Ratos , Ratos Wistar , Valores de Referência , Sistema Nervoso Simpático/efeitos dos fármacos , Sinapses/efeitos dos fármacos , Sinapses/fisiologia
20.
Praxis (Bern 1994) ; 84(10): 281-7, 1995 Mar 07.
Artigo em Alemão | MEDLINE | ID: mdl-7892548

RESUMO

Beta blockers are drugs of first choice for the treatment of essential hypertension today and may be combined with other antihypertensive drugs or diuretics. Use of highly selective beta-1 receptor-blocking agents without intrinsic sympathomimetic activity is particularly recommended for hypertensive patients after transmural myocardial infarction who suffer from exercise-dependent myocardial ischemia. Highly selective beta-1 receptor-blocking agents have only little influence on the lipid metabolism; however, if prescribed in diabetic patients treated with insulin, in patients with cardiac failure or in asthmatic patients, close supervision is mandatory.


Assuntos
Antagonistas Adrenérgicos beta/uso terapêutico , Hipertensão/tratamento farmacológico , Antagonistas Adrenérgicos beta/efeitos adversos , Glicemia , Broncoconstrição/efeitos dos fármacos , Cardiomegalia/tratamento farmacológico , Contraindicações , Insuficiência Cardíaca/induzido quimicamente , Humanos , Metabolismo dos Lipídeos , Qualidade de Vida , Receptores Adrenérgicos beta 1/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA